Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Efficacy of Non-Acetylcholinesterase Therapies in Cognitive Decline

Efficacy of Non-Acetylcholinesterase Therapies in Cognitive Decline

Ojo, Iyanuloluwa
Oral, Onur

Paperback

Medical Reference

ISBN10: 6207808630
ISBN13: 9786207808632
Publisher: LAP Lambert Academic Publishing
Published: Apr 24 2025
Pages: 84
Weight: 0.27
Height: 0.20 Width: 6.00 Depth: 9.00
Language: English
Cognitive decline in aging populations, particularly among those diagnosed with mild cognitive impairment (MCI) and Alzheimer's disease (AD), poses an increasing public health challenge. For decades, acetylcholinesterase inhibitors have remained the cornerstone of pharmacologic intervention in these groups. However, growing concerns about their cardiovascular and respiratory adverse effects - especially in elderly patients with multiple comorbidities - necessitate the exploration of alternative therapies with safer profiles and potentially superior efficacy.This work presents the findings of a systematic review and meta-analysis aimed at identifying and evaluating non-acetylcholinesterase treatments for cognitive decline in patients with MCI, AD, or in individuals aged 65 years and above. We conducted a rigorous literature search of PubMed and the Cochrane Library, covering studies published between January 1, 1990, and September 30, 2024. Eligible studies included randomized clinical trials and longitudinal follow-ups that utilized standardized neurological assessments to measure cognitive outcomes.

Also from

Ojo, Iyanuloluwa

View All

Also in

Medical Reference

View All